新型抗返流可生物降解输尿管支架的动物模型评估
BDG-ARS未出现膀胱输尿管返流,降解可控且无梗阻碎片,但尿培养阳性率50%、迁移率16.6%。
要点
- BDG-ARS可避免膀胱输尿管返流和膀胱三角区刺激
- BDG-ARS在第3至6周可控降解,无梗阻碎片
- 两组BDG-ARS的迁移率均为16.6%
核心结论
- BDG-ARS避免了膀胱输尿管返流和膀胱三角区刺激,并实现一致降解且无梗阻碎片,可能减少支架相关并发症。
主要发现
- 接受BDG-ARS的输尿管均未出现膀胱输尿管返流(VUR)。
- BDG-ARS在第3至6周以可控且可预测的方式降解,未出现梗阻碎片。
- 组I与组II在被动输尿管扩张方面无差异,但在VUR和输尿管口损伤方面存在显著差异。
- BDG-ARS始终维持远端输尿管蠕动。
- 组III的BDG-ARS尿培养阳性率为50%,两个BDG-ARS组的迁移率均为16.6%。
临床怎么用
- BDG-ARS可能减少支架相关并发症,但需注意尿培养阳性率和迁移风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effects in urinary tract of a new antireflux-biodegradable ureteral stent. MATERIALS AND METHODS: Thirty six ureters belonging to 24 pigs were used. The study began with endoscopic, nephrosonographic, and fluoroscopic assessments. Three study groups of ureters (n = 12) were then specified. In group I, a biodegradable antireflux ureteral stent (BDG-ARS) was inserted in the right ureter of 12 pigs. Group II comprised the left ureter of the same animals, in which a double-pigtail stent was placed for 6 weeks. Group III ureters, belonging to 12 additional animals, were subjected to a ureteropelvic junction obstruction model that was then treated by endopyelotomy and stenting with BDG-ARS. Follow-ups were performed at 3-6 weeks and at 5 months. RESULTS: None of the ureters receiving the BDG-ARS showed any evidence of vesicoureteral reflux (VUR). BDG-ARS degradation took place in a controlled and predictable fashion from the third to the sixth weeks, and no obstructive fragments appeared. No differences were found between groups I and II regarding passive ureteral dilation, but significant differences were found regarding VUR and ureteral orifice damage. BDG-ARS always maintained distal ureteral peristalsis. BDG-ARS in group III showed a 50% positive urine culture rate and a 16.6% migration rate in both BDG-ARS groups. CONCLUSION: BDG-ARS avoided VUR and bladder trigone irritation. In addition, this polymer combination and stent-braided design achieved a consistent biodegradation rate with no obstructive fragments and with uniform degradation between the third and the sixth weeks. Consequently, morbidity associated with ureteral stents might be reduced.
引用
- Soria F, Morcillo E, Serrano A, et al. Evaluation of a New Design of Antireflux-biodegradable Ureteral Stent in Animal Model. Urology. 2018. PMID: 29470998. doi:10.1016/j.urology.2018.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。